Henan Taloph Pharmaceutical Stock Co Ltd (600222) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.014x

Based on the latest financial reports, Henan Taloph Pharmaceutical Stock Co Ltd (600222) has a cash flow conversion efficiency ratio of 0.014x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥22.69 Million ≈ $3.32 Million USD) by net assets (CN¥1.65 Billion ≈ $241.37 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Henan Taloph Pharmaceutical Stock Co Ltd's balance sheet to measure how much of total assets are equity-financed.

Henan Taloph Pharmaceutical Stock Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Henan Taloph Pharmaceutical Stock Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Henan Taloph Pharmaceutical Stock Co Ltd to evaluate the quality of earnings relative to operating cash generation.

Henan Taloph Pharmaceutical Stock Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Henan Taloph Pharmaceutical Stock Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
PTC India Limited NSE:PTC	0.317x
Fundamenta Real Estate AG SW:FREN	0.017x
Semen Indonesia Persero Tbk JK:SMGR	0.012x
Merry Electronics Co Ltd TW:2439	-0.111x
Red River Bancshares Inc NASDAQ:RRBI	0.045x
Beijing Science Sun Pharmaceutical Co Ltd SHE:300485	0.008x
Rosenbauer International AG VI:ROS	-0.110x
Anhui Coreach Technology Co Ltd SHE:002983	0.067x

Annual Cash Flow Conversion Efficiency for Henan Taloph Pharmaceutical Stock Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Henan Taloph Pharmaceutical Stock Co Ltd from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see Henan Taloph Pharmaceutical Stock Co Ltd (600222) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.66 Billion ≈ $243.28 Million	CN¥47.16 Million ≈ $6.90 Million	0.028x	+216.53%
2024-12-31	CN¥1.63 Billion ≈ $237.97 Million	CN¥-39.59 Million ≈ $-5.79 Million	-0.024x	-190.35%
2023-12-31	CN¥1.62 Billion ≈ $237.55 Million	CN¥43.74 Million ≈ $6.40 Million	0.027x	+134.96%
2022-12-31	CN¥1.61 Billion ≈ $236.19 Million	CN¥-124.41 Million ≈ $-18.20 Million	-0.077x	-237.49%
2021-12-31	CN¥1.78 Billion ≈ $260.12 Million	CN¥99.66 Million ≈ $14.58 Million	0.056x	+16.86%
2020-12-31	CN¥1.53 Billion ≈ $223.97 Million	CN¥73.43 Million ≈ $10.74 Million	0.048x	+51.55%
2019-12-31	CN¥1.31 Billion ≈ $191.96 Million	CN¥41.53 Million ≈ $6.08 Million	0.032x	-63.14%
2018-12-31	CN¥1.39 Billion ≈ $203.58 Million	CN¥119.47 Million ≈ $17.48 Million	0.086x	+459.02%
2017-12-31	CN¥1.51 Billion ≈ $220.70 Million	CN¥23.17 Million ≈ $3.39 Million	0.015x	-67.36%
2016-12-31	CN¥1.50 Billion ≈ $219.49 Million	CN¥70.60 Million ≈ $10.33 Million	0.047x	+43.24%
2015-12-31	CN¥1.50 Billion ≈ $219.41 Million	CN¥49.27 Million ≈ $7.21 Million	0.033x	-56.47%
2014-12-31	CN¥1.19 Billion ≈ $173.57 Million	CN¥89.54 Million ≈ $13.10 Million	0.075x	+1340.44%
2013-12-31	CN¥1.09 Billion ≈ $159.85 Million	CN¥-6.65 Million ≈ $-972.81K	-0.006x	-104.57%
2012-12-31	CN¥656.50 Million ≈ $96.07 Million	CN¥87.45 Million ≈ $12.80 Million	0.133x	+79526.32%
2011-12-31	CN¥628.89 Million ≈ $92.03 Million	CN¥105.20K ≈ $15.39K	0.000x	+100.51%
2010-12-31	CN¥609.32 Million ≈ $89.16 Million	CN¥-20.00 Million ≈ $-2.93 Million	-0.033x	-189.72%
2009-12-31	CN¥586.04 Million ≈ $85.76 Million	CN¥21.45 Million ≈ $3.14 Million	0.037x	+12.00%
2008-12-31	CN¥554.97 Million ≈ $81.21 Million	CN¥18.13 Million ≈ $2.65 Million	0.033x	-20.12%
2007-12-31	CN¥521.57 Million ≈ $76.32 Million	CN¥21.34 Million ≈ $3.12 Million	0.041x	+1149.87%
2006-12-31	CN¥487.05 Million ≈ $71.27 Million	CN¥1.59 Million ≈ $233.25K	0.003x	+459.04%
2005-12-31	CN¥471.96 Million ≈ $69.06 Million	CN¥276.30K ≈ $40.43K	0.001x	-98.54%
2004-12-31	CN¥455.68 Million ≈ $66.68 Million	CN¥18.25 Million ≈ $2.67 Million	0.040x	+371.94%
2003-12-31	CN¥440.61 Million ≈ $64.48 Million	CN¥3.74 Million ≈ $547.22K	0.008x	-51.32%
2002-12-31	CN¥428.30 Million ≈ $62.67 Million	CN¥7.47 Million ≈ $1.09 Million	0.017x	-86.79%
2001-12-31	CN¥416.84 Million ≈ $61.00 Million	CN¥55.03 Million ≈ $8.05 Million	0.132x	+6089.51%
2000-12-31	CN¥410.41 Million ≈ $60.06 Million	CN¥875.36K ≈ $128.09K	0.002x	-99.14%
1999-12-31	CN¥401.57 Million ≈ $58.76 Million	CN¥99.32 Million ≈ $14.53 Million	0.247x	+36.58%
1998-12-31	CN¥154.84 Million ≈ $22.66 Million	CN¥28.04 Million ≈ $4.10 Million	0.181x	--

About Henan Taloph Pharmaceutical Stock Co Ltd

SHG:600222 China Drug Manufacturers - Specialty & Generic

Market Cap

$640.75 Million

CN¥4.38 Billion CNY

Market Cap Rank

#10980 Global

#3027 in China

Share Price

CN¥7.63

Change (1 day)

+2.55%

52-Week Range

CN¥6.26 - CN¥8.70

All Time High

CN¥10.35